An examination of aneurysm rerupture rates with epsilon aminocaproic acid

Albert J. Schuette, Ferdinand K. Hui, Nancy A. Obuchowski, Raymond R. Walkup, Charles M. Cawley, Daniel L. Barrow, Owen B. Samuels

Research output: Contribution to journalArticle

Abstract

Background: Epsilon aminocaproic acid (EACA) has been used in the past to prevent cerebral aneurysm rerupture. Recent studies have indicated that short-term treatment with EACA can lower rebleeding rates without significantly increasing ischemic or thrombotic complications or permanent shunt rates. The goal of this study is to determine the efficacy of EACA in the prevention of aneurysm rerupture at a high volume subarachnoid hemorrhage center. Methods: We conducted a retrospective study of 355 consecutive subarachnoid hemorrhage patients over a 2-year period under our current protocol for EACA use. Patients were divided by presentation time to our institution and whether the patient received EACA. The primary endpoints of the study were rebleeding rates, ischemic complications, thrombotic complications, vasospasm, shunt rates, and outcomes. Results: Rerupture rates were reduced by half in the entire pool of patients on EACA after controlling for Hunt and Hess Scores and Fisher Scores. In patients who received early aneurysm treatment, this effect persisted but was non-statistically significant due to the small numbers of reruptures. In addition, there was no evidence to suggest that EACA increased ischemic or thrombotic complications, vasospasm, or VPS rates. In patients presenting earlier than 24 h to our institution, there was a non-significant trend toward worse outcomes after EACA use. This trend was reversed in patients arriving after 24 h. Conclusion: There is evidence to suggest that EACA is protective from aneurysm rerupture without significant ischemic or thrombotic complications when used for less than 72 h. However, if the aneurysm is treated, this effect is modest indicating that early aneurysm treatment remains the gold standard for rerupture prevention.

Original languageEnglish (US)
Pages (from-to)48-55
Number of pages8
JournalNeurocritical care
Volume19
Issue number1
DOIs
StatePublished - Aug 1 2013
Externally publishedYes

Keywords

  • Aminocaproic acid
  • Aneurysm rerupture
  • Rerupture
  • Subarachnoid hemorrhage
  • Vasospasm

ASJC Scopus subject areas

  • Clinical Neurology
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'An examination of aneurysm rerupture rates with epsilon aminocaproic acid'. Together they form a unique fingerprint.

  • Cite this

    Schuette, A. J., Hui, F. K., Obuchowski, N. A., Walkup, R. R., Cawley, C. M., Barrow, D. L., & Samuels, O. B. (2013). An examination of aneurysm rerupture rates with epsilon aminocaproic acid. Neurocritical care, 19(1), 48-55. https://doi.org/10.1007/s12028-012-9735-8